Curexo Inc. (KOSDAQ:060280)
8,020.00
-150.00 (-1.84%)
Sep 11, 2026, 3:30 PM KST
Curexo Revenue
Curexo had revenue of 23.62B KRW in the quarter ending June 30, 2026, with 40.63% growth. This brings the company's revenue in the last twelve months to 77.74B, up 20.38% year-over-year. In the year 2025, Curexo had annual revenue of 74.53B with 34.22% growth.
Revenue (ttm)
77.74B
Revenue Growth
+20.38%
P/S Ratio
4.26
Revenue / Employee
713.22M
Employees
109
Market Cap
330.90B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 74.53B | 19.00B | 34.22% |
| Dec 31, 2024 | 55.53B | 28.00B | 101.72% |
| Dec 31, 2015 | 27.53B | 1.39B | 5.33% |
| Dec 31, 2014 | 26.14B | -4.95B | -15.93% |
| Dec 31, 2013 | 31.09B | 6.81B | 28.05% |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Value Added Technology | 441.04B |
| i-SENS | 326.19B |
| Vieworks | 244.28B |
| T&L Co., Ltd. | 175.16B |
| Boditech Med | 174.78B |
| WON TECH | 167.35B |
| BioNote | 126.41B |
| Bio Plus | 99.15B |